Skip to main content
. 2016 Nov 23;7(52):87180–87193. doi: 10.18632/oncotarget.13517

Table 7. The associations between rs4149867 and clinical characteristics of hepatocellular carcinoma patients.

Variables AA AG/GG OR(95%CI)a OR(95%CI)b
tumor size
 ≥5cm 165(67.07) 81(32.93) 1.000 1.000
 <5cm 501(67.34) 243(32.66) 1.125(0.533∼2.373) 0.638(0.357∼1.138)
tumor number
 solitary 609(69.76) 264(30.24) 1.000 1.000
 multiple 78(66.66) 39(33.34) 1.153(0.765∼1.739) 1.080(0.521∼2.238)
TNM staging
 T1+T2 588(70.25) 249(29.75) 1.000 1.000
 T3+T4 96(64.00) 54(36.00) 1.328(0.922∼1.913) 1.250(0.646∼2.419)
Combined with liver cirrhosis
 Yes 273(65.94) 141(34.06) 1.000 1.000
 No 414(72.25) 159(27.05) 0.744(0.566∼0.977) 0.781(0.480∼1.270)
AFP level (ng/ml)
 ≥400 483(69.40) 213(30.60) 1.000 1.000
 <400 204(69.39) 90(30.61) 1.000(0.744∼1.345) 0.988(0.587∼1.665)
tumor metastasis
 Yes 99(75.00) 33(25.00) 1.000 1.000
 No 582(68.31) 270(31.69) 0.719(0.472∼1.093) 0.726(0.348∼1.515)

a: OR (95% CI) not adjusted; b: OR (95% CI) adjusted for age, gender, nations, smoking, alcohol consumption, HBV infection, and HCC family history.